A finance director is facing insider dealing charges at the Crown Court after
allegedly passing on information about the proposed takeover of Neutec Pharma, a
company which develops treatments for life-threatening infections.
The FSA said Peter Andrew King is charged with disclosing inside information
relating to the proposed takeover of Neutec Pharma to a lawyer Michael McFall,
“having had that inside information by virtue of being Neutec Pharma plc’s
finance director, and disclosing it to Michael McFall other than in the proper
performance of his job.”
McFall allegedly passed the information on to another lawyer Andrew
Rimmington before they both bought shares in Neutec Pharma, which was founded by
professors in 1997.
Following a contested hearing which took place at Westminster Magistrates
Court, District Judge Miss Tubbs remanded King, McFall and Rimmington on
unconditional bail to appear at Southwark Crown Court for a plea and case
management hearing on 28 October 2009.
Does Darwin's theory apply to taxation? Colin ponders...
The EC has been instructed to draft a European Union (EU) directive authorising an EU financial transaction tax, which would apply to ten of the EU’s 28 member states
Accountancy watchdog the FRC has dropped its investigation into the former chief financial officer of Tesco, nearly two years after the supermarket was engulfed in an accounting scandal
Colin imagines how Apple's logo might change in the wake of the EC's ruling over its Irish tax arrangements